US equities
|
SPCX
$147.79
▲+0.00%
NVDA
$216.47
▲+0.00%
MU
$896.07
▲+0.00%
TSLA
$373.71
▲+0.00%
SNDK
$1,365.38
▲+0.00%
GOOGL
$340.27
▲+0.00%
NFLX
$68.69
▲+0.00%
AMD
$534.74
▲+0.00%
SPCX
$147.79
▲+0.00%
NVDA
$216.47
▲+0.00%
MU
$896.07
▲+0.00%
TSLA
$373.71
▲+0.00%
SNDK
$1,365.38
▲+0.00%
GOOGL
$340.27
▲+0.00%
NFLX
$68.69
▲+0.00%
AMD
$534.74
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Eye Diseases
Recent news which mentions Eye Diseases
Adverum's Single Dose Wet AMD Gene Therapy Shows Robust Two Year Durability, Safety
October 04, 2021
Tickers
ADVM
Tags
gene therapy
Market News
Biotech
From
Benzinga
Why Are Viridian Therapeutics Shares Moving Higher On Tuesday?
September 21, 2021
Tickers
VRDN
Tags
Long Ideas
Eye Diseases
Briefs
From
Benzinga
Novartis Adds Vision Loss Gene Therapy Program Via Arctos Acquisition
September 21, 2021
Tickers
NVS
Tags
NVS
Market News
gene therapy
From
Benzinga